These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12922128)
21. The Chesson strain of plasmodium vivax in humans and different species of Aotus monkeys. Collins WE; Sullivan JS; Jeffery GM; Williams A; Galland GG; Nace D; Williams T; Barnwell JW Am J Trop Med Hyg; 2009 Jan; 80(1):152-9. PubMed ID: 19141854 [TBL] [Abstract][Full Text] [Related]
22. Aotus lemurinus griseimembra monkeys: a suitable model for Plasmodium vivax sporozoite infection. Jordan-Villegas A; Zapata JC; Perdomo AB; Quintero GE; Solarte Y; Arévalo-Herrera M; Herrera S Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):10-5. PubMed ID: 16291761 [TBL] [Abstract][Full Text] [Related]
23. Induction of transmission-blocking immunity in Aotus monkeys by vaccination with a Plasmodium vivax clinical grade PVS25 recombinant protein. Arévalo-Herrera M; Solarte Y; Yasnot MF; Castellanos A; Rincón A; Saul A; Mu J; Long C; Miller L; Herrera S Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):32-7. PubMed ID: 16291764 [TBL] [Abstract][Full Text] [Related]
24. Adaptation of the AMRU-1 strain of Plasmodium vivax to Aotus and Saimiri monkeys and to four species of anopheline mosquitoes. Sullivan JS; Morris CL; Richardson BB; Galland GG; Jennings VM; Kendall J; Collins WE J Parasitol; 1999 Aug; 85(4):672-7. PubMed ID: 10461947 [TBL] [Abstract][Full Text] [Related]
25. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit. Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762 [TBL] [Abstract][Full Text] [Related]
26. Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys. Collins WE; Sullivan JS; Fryauff DJ; Kendall J; Jennings V; Galland GG; Morris CL Am J Trop Med Hyg; 2000 Apr; 62(4):491-5. PubMed ID: 11220765 [TBL] [Abstract][Full Text] [Related]
27. Studies of a chloroquine-resistant strain of Plasmodium vivax from Papua New Guinea in Aotus and Anopheles farauti s.l. Cooper RD J Parasitol; 1994 Oct; 80(5):789-95. PubMed ID: 7931914 [TBL] [Abstract][Full Text] [Related]
28. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection. Giraldo MA; Arevalo-Pinzon G; Rojas-Caraballo J; Mongui A; Rodriguez R; Patarroyo MA Vaccine; 2009 Dec; 28(1):7-13. PubMed ID: 19782110 [TBL] [Abstract][Full Text] [Related]
29. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439 [TBL] [Abstract][Full Text] [Related]
30. Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides. Sierra AY; Barrero CA; Rodriguez R; Silva Y; Moncada C; Vanegas M; Patarroyo MA Vaccine; 2003 Oct; 21(27-30):4133-44. PubMed ID: 14505893 [TBL] [Abstract][Full Text] [Related]
31. Nonhuman primate models. II. Infection of Saimiri and Aotus monkeys with Plasmodium vivax. Collins WE Methods Mol Med; 2002; 72():85-92. PubMed ID: 12125161 [No Abstract] [Full Text] [Related]
32. Plasmodium vivax vaccine research - we've only just begun. Tham WH; Beeson JG; Rayner JC Int J Parasitol; 2017 Feb; 47(2-3):111-118. PubMed ID: 27899329 [TBL] [Abstract][Full Text] [Related]
33. Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development. Asali S; Raz A; Turki H; Mafakher L; Razmjou E; Solaymani-Mohammadi S Infect Genet Evol; 2021 Apr; 89():104710. PubMed ID: 33421653 [TBL] [Abstract][Full Text] [Related]
34. Adaptation of a strain of Plasmodium vivax from India to New World monkeys, chimpanzees, and anopheline mosquitoes. Sullivan JS; Strobert E; Yang C; Morris CL; Galland GG; Richardson BB; Bounngaseng A; Kendall J; McClure H; Collins WE J Parasitol; 2001 Dec; 87(6):1398-403. PubMed ID: 11780828 [TBL] [Abstract][Full Text] [Related]
35. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran. Zakeri S; Razavi S; Djadid ND Acta Trop; 2009 Mar; 109(3):176-80. PubMed ID: 18950597 [TBL] [Abstract][Full Text] [Related]
36. Experimental infection of the neotropical malaria vector Anopheles darlingi by human patient-derived Plasmodium vivax in the Peruvian Amazon. Bharti AR; Chuquiyauri R; Brouwer KC; Stancil J; Lin J; Llanos-Cuentas A; Vinetz JM Am J Trop Med Hyg; 2006 Oct; 75(4):610-6. PubMed ID: 17038681 [TBL] [Abstract][Full Text] [Related]
37. A comparative study on worldwide genetic diversity and population structure analysis of Plasmodium vivax thrombospondin-related adhesive protein (PvTRAP) and its implications for the vivax vaccine design. Nazeri S; Mehrizi AA; Djadid ND; Zakeri S Infect Genet Evol; 2015 Dec; 36():410-423. PubMed ID: 26477931 [TBL] [Abstract][Full Text] [Related]
38. The susceptibility of the Indonesian I/CDC strain of Plasmodium vivax to chloroquine. Collins WE; Schwartz IK; Skinner JC; Morris C; Filipski VK J Parasitol; 1992 Apr; 78(2):344-9. PubMed ID: 1556649 [TBL] [Abstract][Full Text] [Related]
39. Overview: immunology of malaria and progress in malaria vaccine development. Tharavanij S Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871 [No Abstract] [Full Text] [Related]
40. Further studies on the sporozoite transmission of the Salvador I strain of Plasmodium vivax. Collins WE; Morris CL; Richardson BB; Sullivan JS; Galland GG J Parasitol; 1994 Aug; 80(4):512-7. PubMed ID: 8064516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]